XAGE Cash from operations

annual CFO:

-$4.39M+$3.96M(+47.43%)
December 31, 2024

Summary

  • As of today (August 25, 2025), XAGE annual cash flow from operations is -$4.39 million, with the most recent change of +$3.96 million (+47.43%) on December 31, 2024.
  • During the last 3 years, XAGE annual CFO has fallen by -$3.21 million (-272.95%).
  • XAGE annual CFO is now -272.95% below its all-time high of -$1.18 million, reached on December 1, 2021.

Performance

1-year change

+47.43%

3-year change

-272.95%

5-year change

-272.95%

15-year change

-272.95%

XAGE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

16.79%
XAGE annual cash flow from operations is higher than 16.79% of companies in Consumer Defensive sector

Range

All-time high

-$1.18M

3-year low

-$8.35M

Earnings dates

Last annual earnings report date

Dec 31, 2024
XAGE previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
XAGE next annual earnings announcement has not yet been scheduled

OtherXAGEcash flow metrics

annual CFI

-$748.80K
XAGE annual cash flow from investing activities is -$748.80 thousand

annual CFF

$2.38M
XAGE annual cash flow from financing activities is $2.38 million

annual FCF

-$4.39M
XAGE annual free cash flow is -$4.39 million

annual CAPEX

$0.00
XAGE annual capital expenditures is $0.00

quarterly CFO:

-$836.20K-$83.20K(-11.05%)
June 30, 2025

Summary

  • As of today (August 25, 2025), XAGE quarterly cash flow from operations is -$836.20 thousand, with the most recent change of -$83.20 thousand (-11.05%) on June 30, 2025.
  • Over the past year, XAGE quarterly CFO has increased by +$302.30 thousand (+26.55%).

Performance

3-month change

-11.05%

1-year change

+26.55%

3-year change

-1835.65%

5-year change

-100%

XAGE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

23.5%
XAGE quarterly cash flow from operations is higher than 23.5% of companies in Consumer Defensive sector

Range

All-time high

$0.00
XAGE quarterly cash flow from operations is currently <-9900.00% below its historical high of $0.00

3-year low

-$3.98M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
XAGE previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 14, 2025
XAGE next earnings announcement is scheduled for Nov 14, 2025

OtherXAGEcash flow metrics

quarterly CFI

-$15.00K
XAGE quarterly cash flow from investing activities is -$15.00 thousand

quarterly CFF

$1.63M
XAGE quarterly cash flow from financing activities is $1.63 million

quarterly FCF

-$836.20K
XAGE quarterly free cash flow is -$836.20 thousand

quarterly CAPEX

$0.00
XAGE quarterly capital expenditures is $0.00

TTM CFO:

-$3.76M+$302.30K(+7.43%)
June 30, 2025

Summary

  • As of today (August 25, 2025), XAGE TTM cash flow from operations is -$3.76 million, with the most recent change of +$302.30 thousand (+7.43%) on June 30, 2025.
  • Over the past year, XAGE TTM CFO has increased by +$2.43 million (+39.24%).

Performance

3-month change

+7.43%

1-year change

+39.24%

3-year change

-488.39%

5-year change

-100%

XAGE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

16.59%
XAGE TTM cash flow from operations is higher than 16.59% of companies in Consumer Defensive sector

Range

All-time high

$0.00
XAGE TTM cash flow from operations is currently <-9900.00% below its historical high of $0.00

3-year low

-$7.62M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
XAGE previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 14, 2025
XAGE next earnings announcement is scheduled for Nov 14, 2025

OtherXAGEcash flow metrics

TTM CFI

-$165.00K
XAGE TTM cash flow from investing activities is -$165.00 thousand

TTM CFF

$3.28M
XAGE TTM cash flow from financing activities is $3.28 million

TTM FCF

-$3.76M
XAGE TTM free cash flow is -$3.76 million

TTM CAPEX

$0.00
XAGE TTM capital expenditures is $0.00

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

XAGE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.4%+26.6%+39.2%
3 y3 years-272.9%-1835.7%-488.4%
5 y5 years-272.9%-100.0%-100.0%

XAGE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-272.9%+47.4%-1835.7%+79.0%-488.4%+50.6%
5 y5-year-272.9%+47.4%<-9999.0%+79.0%<-9999.0%+50.6%
alltimeall time-272.9%+47.4%<-9999.0%+79.0%<-9999.0%+50.6%

XAGE Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$836.20K(+11.0%)
-$3.76M(-7.4%)
Mar 2025
-
-$753.00K(-2.5%)
-$4.07M(-7.4%)
Dec 2024
-$4.39M(-47.4%)
-$772.10K(-45.0%)
-$4.39M(+21.3%)
Sep 2024
-
-$1.40M(+23.2%)
-$3.62M(-41.6%)
Jun 2024
-
-$1.14M(+5.8%)
-$6.20M(+11.9%)
Mar 2024
-
-$1.08M(-73.0%)
-$5.54M(-27.3%)
Dec 2023
-$8.35M
-
-
Sep 2023
-
-$3.98M(+729.0%)
-$7.62M(+66.6%)
Jun 2023
-
-$480.20K(+0.9%)
-$4.57M(+10.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$476.00K(-82.2%)
-$4.14M(+8.5%)
Dec 2022
-$3.43M(+191.4%)
-$2.68M(+186.9%)
-$3.81M(+217.5%)
Sep 2022
-
-$934.60K(+2063.4%)
-$1.20M(+87.7%)
Jun 2022
-
-$43.20K(-71.5%)
-$639.70K(+6.1%)
Mar 2022
-
-$151.70K(+114.0%)
-$602.90K(+33.6%)
Dec 2021
-$1.18M
-$70.90K(-81.0%)
-$451.20K(+18.6%)
Sep 2021
-
-$373.90K(+5742.2%)
-$380.30K(+5842.2%)
Jun 2021
-
-$6400.00(<-9900.0%)
-$6400.00(<-9900.0%)
Mar 2021
-
$0.00
$0.00

FAQ

  • What is Longevity Health Holdings, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Longevity Health Holdings, Inc.?
  • What is Longevity Health Holdings, Inc. annual CFO year-on-year change?
  • What is Longevity Health Holdings, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Longevity Health Holdings, Inc.?
  • What is Longevity Health Holdings, Inc. quarterly CFO year-on-year change?
  • What is Longevity Health Holdings, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Longevity Health Holdings, Inc.?
  • What is Longevity Health Holdings, Inc. TTM CFO year-on-year change?

What is Longevity Health Holdings, Inc. annual cash flow from operations?

The current annual CFO of XAGE is -$4.39M

What is the all time high annual CFO for Longevity Health Holdings, Inc.?

Longevity Health Holdings, Inc. all-time high annual cash flow from operations is -$1.18M

What is Longevity Health Holdings, Inc. annual CFO year-on-year change?

Over the past year, XAGE annual cash flow from operations has changed by +$3.96M (+47.43%)

What is Longevity Health Holdings, Inc. quarterly cash flow from operations?

The current quarterly CFO of XAGE is -$836.20K

What is the all time high quarterly CFO for Longevity Health Holdings, Inc.?

Longevity Health Holdings, Inc. all-time high quarterly cash flow from operations is $0.00

What is Longevity Health Holdings, Inc. quarterly CFO year-on-year change?

Over the past year, XAGE quarterly cash flow from operations has changed by +$302.30K (+26.55%)

What is Longevity Health Holdings, Inc. TTM cash flow from operations?

The current TTM CFO of XAGE is -$3.76M

What is the all time high TTM CFO for Longevity Health Holdings, Inc.?

Longevity Health Holdings, Inc. all-time high TTM cash flow from operations is $0.00

What is Longevity Health Holdings, Inc. TTM CFO year-on-year change?

Over the past year, XAGE TTM cash flow from operations has changed by +$2.43M (+39.24%)
On this page